ctDNA-based molecular residual disease and survival in resectable colorectal cancer
ctDNA-based molecular residual disease and survival in resectable colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ctDNA-based molecular residual disease and survival in resectable colorectal cancer have?
ctDNA-based molecular residual disease and survival in resectable colorectal cancer has 212 citations in the OpenAlex counts ScholarIQ stores.
When was ctDNA-based molecular residual disease and survival in resectable colorectal cancer published?
ctDNA-based molecular residual disease and survival in resectable colorectal cancer has 2024 year in the ScholarIQ index.
What is the open-access status of ctDNA-based molecular residual disease and survival in resectable colorectal cancer?
ctDNA-based molecular residual disease and survival in resectable colorectal cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of ctDNA-based molecular residual disease and survival in resectable colorectal cancer?
The DOI for ctDNA-based molecular residual disease and survival in resectable colorectal cancer is on the source record.
What is the PMID of ctDNA-based molecular residual disease and survival in resectable colorectal cancer?
The PMID for ctDNA-based molecular residual disease and survival in resectable colorectal cancer is on the source record.
What is the OpenAlex record for ctDNA-based molecular residual disease and survival in resectable colorectal cancer?
The OpenAlex for ctDNA-based molecular residual disease and survival in resectable colorectal cancer is on the source record.